絞り込み

17407

広告

「"ageno w"[Author]」の検索結果

502件中 161件~180件表示    検索結果をPubMedで見る PubMedで見る

Guidance for the management of venous thrombosis in unusual sites.

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis.

Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study.

TREATING PATIENTS WITH CANCER AND ACUTE VENOUS THROMBOEMBOLISM.

Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study.

Treatment of pulmonary embolism.

Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.

Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study.

Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis.

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.

Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort.

Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy.

A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study.

Rivaroxaban: An Evaluation of its Cardiovascular Benefit-Risk Profile Across Indications Based on Numbers Needed to Treat or Harm, and on Clinically Meaningful Endpoint Comparisons.

Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.

Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: reply.

Small clots with large impact.

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.

Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes.

  1. 5
  2. 6
  3. 7
  4. 8
  5. 9
  6. 10
  7. 11
  8. 12
Sort by
※並べ替えは表示に時間がかかります